Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brigitte Siani"'
Autor:
Martin Imboden, Liane Hoefferer, Adriano Marques Antunes, Annette Gaida, Isabelle Glauser, Brigitte Siani, Ibrahim El Menyawi, Reinhard Bolli, Katharina Willimann, Eleonora Widmer, Sandra Wymann, Martin O. Spycher
Publikováno v:
Transfusion. 55:S117-S121
BACKGROUND The passive transfer of antibodies specific to blood groups A and B (also called isoagglutinins) contained in immunoglobulin (Ig)G products for intravenous administration (IVIG) is believed to be largely responsible for rare but sometimes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b64557d01dabf20df687e12c73969ae8
https://doi.org/10.1111/trf.13088
https://doi.org/10.1111/trf.13088
Publikováno v:
Transfusion. 55:S95-S97
BACKGROUND Hemolysis reaction is a rare class effect of therapy with intravenously administered human normal immunoglobulin (IVIG). Anti-A/B isoagglutinins (isohemagglutinins) originating from donor plasma are considered a probable risk factor for he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc856a601751475d3dfa9ef1382cb48e
https://doi.org/10.1111/trf.13095
https://doi.org/10.1111/trf.13095
Autor:
Liane, Hoefferer, Isabelle, Glauser, Annette, Gaida, Katharina, Willimann, Adriano, Marques Antunes, Brigitte, Siani, Sandra, Wymann, Eleonora, Widmer, Ibrahim, El Menyawi, Reinhard, Bolli, Martin, Spycher, Martin, Imboden
Publikováno v:
Transfusion. 55
The passive transfer of antibodies specific to blood groups A and B (also called isoagglutinins) contained in immunoglobulin (Ig)G products for intravenous administration (IVIG) is believed to be largely responsible for rare but sometimes serious IVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::702de55d25cf20e1bf336e02ff119a1d
https://pubmed.ncbi.nlm.nih.gov/26174889
https://pubmed.ncbi.nlm.nih.gov/26174889
Autor:
Brigitte, Siani, Katharina, Willimann, Sandra, Wymann, Adriano, Marques Antunes, Eleonora, Widmer
Publikováno v:
Transfusion. 55
Hemolysis reaction is a rare class effect of therapy with intravenously administered human normal immunoglobulin (IVIG). Anti-A/B isoagglutinins (isohemagglutinins) originating from donor plasma are considered a probable risk factor for hemolysis. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3deba257d85e7c58a349f525e52b935
https://pubmed.ncbi.nlm.nih.gov/26174905
https://pubmed.ncbi.nlm.nih.gov/26174905
Publikováno v:
Biologics in Therapy
Introduction Hemolysis is considered a class effect and a rare adverse event that can occur following therapy with human normal immunoglobulin for intravenous administration [i.e., intravenous immunoglobulin (IVIG)]. Anti-A/B isoagglutinins (also ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1736ffc5c24a2e96485d80fb9eeec6
https://pubmed.ncbi.nlm.nih.gov/24841428
https://pubmed.ncbi.nlm.nih.gov/24841428
Autor:
Annette Gaida, Katharina Willimann, Ibrahim El Menyawi, Liane Hoefferer, A. Adriano Marques, Martin Imboden, Sandra Wymann, Isabelle Glauser, Reinhard Bolli, Eleanora Widmer, Brigitte Siani
Publikováno v:
Journal of Allergy and Clinical Immunology. 135:AB97
S U N D A Y 311 Selective Exclusion of High Titer Donor Plasma and Immunoadsorption Chromatography As Steps to Reduce Isoagglutinin Titers in IVIG Liane Hoefferer, Ibrahim El Menyawi, Brigitte Siani, Martin Imboden, Annette Gaida, Isabelle Glauser, R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2bf75100ba86b5f925f1c73ea83fb08
https://doi.org/10.1016/j.jaci.2014.12.1249
https://doi.org/10.1016/j.jaci.2014.12.1249